Theravance Biopharma (TBPH) EBT Margin Growth (5y) (2018 - 2026)
Theravance Biopharma (TBPH) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,073.00 |
| Dec 31, 2025 | 56,246.00 |
| Sep 30, 2025 | 38,841.00 |
| Jun 30, 2025 | 69,823.00 |
| Mar 31, 2025 | 32,553.00 |
| Dec 31, 2024 | -2,035.00 |
| Sep 30, 2024 | 45,528.00 |
| Jun 30, 2024 | -3,337.00 |
| Mar 31, 2024 | 128,646.00 |
| Dec 31, 2023 | 31,104.00 |
| Sep 30, 2023 | 41,976.00 |
| Jun 30, 2023 | 9,961.00 |
| Mar 31, 2023 | 56,483.00 |
| Dec 31, 2022 | 167,305.00 |
| Sep 30, 2022 | 141,538.00 |
| Jun 30, 2022 | 166,980.00 |
| Mar 31, 2022 | 164,045.00 |
| Dec 31, 2021 | 64,458.00 |
| Sep 30, 2021 | -25,002.00 |
| Jun 30, 2021 | -9,291.00 |